Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Biotheranostics
gptkb:Diagenode gptkb:Gen-Probe gptkb:Mobidiag |
| gptkbp:CEO |
gptkb:Stephen_P._MacMillan
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:founded |
1985
|
| gptkbp:founder |
gptkb:David_Ellenbogen
|
| gptkbp:headquartersLocation |
gptkb:Marlborough,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Hologic
|
| gptkbp:industry |
medical device
|
| gptkbp:ISIN |
US4364401012
|
| gptkbp:notableProduct |
gptkb:Aptima_assays
gptkb:ThinPrep_Pap_Test Mammography systems |
| gptkbp:numberOfEmployees |
~6,500
|
| gptkbp:products |
medical imaging
diagnostic products molecular diagnostic systems surgical products |
| gptkbp:publiclyTraded |
gptkb:NASDAQ
|
| gptkbp:revenue |
$5.07 billion (2023)
|
| gptkbp:specializesIn |
women's health
breast health gynecological health skeletal health |
| gptkbp:stockSymbol |
gptkb:HOLX
|
| gptkbp:website |
https://www.hologic.com/
|
| gptkbp:bfsParent |
gptkb:WTA
gptkb:Kenneth_W._Freeman |
| gptkbp:bfsLayer |
5
|